Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver

Sam C. Wang, Nicholas Fidelman, Eric K. Nakakura

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Neuroendocrine tumors (NETs) can have indolent clinical courses and patients with metastatic disease may live many years after the initial diagnosis. Recent studies have suggested that aggressive treatments may extend survival. In this review, we assess the recent literature regarding management of well-differentiated NETs from the gastrointestinal (GI) tract metastatic to the liver. We focus on studies regarding surgical resection, embolization, or ablation of hepatic lesions. We also present a management algorithm for patients who present with metastatic lesions but the primary lesion cannot be located. Since NETs are rare, all of the available evidence is based on retrospective studies that have limited sample size. As a result, recommendations are offered with caution.

Original languageEnglish (US)
Pages (from-to)69-74
Number of pages6
JournalSeminars in Oncology
Volume40
Issue number1
DOIs
StatePublished - Feb 2013

Fingerprint

Neuroendocrine Tumors
Liver
Sample Size
Gastrointestinal Tract
Retrospective Studies
Survival
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. / Wang, Sam C.; Fidelman, Nicholas; Nakakura, Eric K.

In: Seminars in Oncology, Vol. 40, No. 1, 02.2013, p. 69-74.

Research output: Contribution to journalArticle

@article{d6df6a5c6be9405b8b8c54ac9defb398,
title = "Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver",
abstract = "Neuroendocrine tumors (NETs) can have indolent clinical courses and patients with metastatic disease may live many years after the initial diagnosis. Recent studies have suggested that aggressive treatments may extend survival. In this review, we assess the recent literature regarding management of well-differentiated NETs from the gastrointestinal (GI) tract metastatic to the liver. We focus on studies regarding surgical resection, embolization, or ablation of hepatic lesions. We also present a management algorithm for patients who present with metastatic lesions but the primary lesion cannot be located. Since NETs are rare, all of the available evidence is based on retrospective studies that have limited sample size. As a result, recommendations are offered with caution.",
author = "Wang, {Sam C.} and Nicholas Fidelman and Nakakura, {Eric K.}",
year = "2013",
month = "2",
doi = "10.1053/j.seminoncol.2012.11.007",
language = "English (US)",
volume = "40",
pages = "69--74",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver

AU - Wang, Sam C.

AU - Fidelman, Nicholas

AU - Nakakura, Eric K.

PY - 2013/2

Y1 - 2013/2

N2 - Neuroendocrine tumors (NETs) can have indolent clinical courses and patients with metastatic disease may live many years after the initial diagnosis. Recent studies have suggested that aggressive treatments may extend survival. In this review, we assess the recent literature regarding management of well-differentiated NETs from the gastrointestinal (GI) tract metastatic to the liver. We focus on studies regarding surgical resection, embolization, or ablation of hepatic lesions. We also present a management algorithm for patients who present with metastatic lesions but the primary lesion cannot be located. Since NETs are rare, all of the available evidence is based on retrospective studies that have limited sample size. As a result, recommendations are offered with caution.

AB - Neuroendocrine tumors (NETs) can have indolent clinical courses and patients with metastatic disease may live many years after the initial diagnosis. Recent studies have suggested that aggressive treatments may extend survival. In this review, we assess the recent literature regarding management of well-differentiated NETs from the gastrointestinal (GI) tract metastatic to the liver. We focus on studies regarding surgical resection, embolization, or ablation of hepatic lesions. We also present a management algorithm for patients who present with metastatic lesions but the primary lesion cannot be located. Since NETs are rare, all of the available evidence is based on retrospective studies that have limited sample size. As a result, recommendations are offered with caution.

UR - http://www.scopus.com/inward/record.url?scp=84873398141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873398141&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2012.11.007

DO - 10.1053/j.seminoncol.2012.11.007

M3 - Article

C2 - 23391114

AN - SCOPUS:84873398141

VL - 40

SP - 69

EP - 74

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 1

ER -